Carperitide in Acute Respiratory Distress Syndrome (ARDS)
NCT00030121 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2008-02-20
Summary
The purpose of this study is to determine whether Carperitide is safe and effective in the management of Acute Respiratory Distress Syndrome (ARDS).
Conditions
- Respiratory Distress Syndrome
Interventions
- DRUG
-
recombinant human atrial natriuretic polypeptide
Sponsors & Collaborators
-
Suntory Pharmaceutical
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-12-31
More Related Trials
-
The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure
NCT02617446 ·Status: COMPLETED ·Phase: PHASE2
-
STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure
NCT00484770 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection
NCT04389801 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)
NCT01733134 ·Status: WITHDRAWN ·Phase: PHASE3
-
Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients
NCT00482287 ·Status: WITHDRAWN ·Phase: PHASE2
-
Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.
NCT00348504 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Recombinant Human Brain Natriuretic Peptide and Dobutamine
NCT01837849 ·Status: COMPLETED
-
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
NCT00252187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
NCT03730961 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
NCT01618448 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation
NCT02832089 ·Status: COMPLETED ·Phase: PHASE3
-
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
NCT01644331 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00234104 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
NCT04632121 ·Status: UNKNOWN
-
Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)
NCT04530604 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
NCT00043771 ·Status: COMPLETED ·Phase: PHASE2
-
Early rhBNP on Myocardial Work in Patients With STEMI
NCT04157868 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure
NCT01661634 ·Status: COMPLETED ·Phase: PHASE3
-
Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure
NCT01543854 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure
NCT05111769 ·Status: UNKNOWN ·Phase: NA
-
First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100
NCT05426746 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
NCT03772041 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
NCT05714085 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
NCT00709865 ·Status: COMPLETED ·Phase: PHASE3
-
Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass
NCT05534802 ·Status: COMPLETED ·Phase: NA